Breakthroughs: Alzheimer's Disease
November, 2010
02:55

Race, Gender and Alzheimer's

To embed this video, copy this code:

Are women and African-Americans at a higher risk for Alzheimer’s—as some data suggests—or are there other factors in play?

Breakthroughs: Alzheimer's Disease

Big Think hosted a panel discussion highlighting cutting-edge Alzheimer's disease research as part of our Breakthroughs series, made possible by Pfizer.

This conversation features back-and-forth exchanges between top luminaries in the field, including Dr. Samuel Gandy, Mount Sinai Professor of Alzheimer's Disease Research; Dr. Leonard Guarente, Director of Glenn Lab for Science of Aging at MIT; Dr. Juan Troncoso, Director of the Brain Resource Center at Johns Hopkins University School of Medicine; and Dr. Ottavio Arancio, Professor of Pathology & Cell Biology at the Columbia University Medical Center.  The panel was moderated by Meryl Comer, President of the Geoffrey Beene Foundation Alzheimer’s Initiative.

 


×